## AZO: AutoZone, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -2.0% below STRENGTH zone (3.0-6.0%); PEG 1.78 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($3170.45)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. These Catalysts Could Drive AutoZone Stock Higher in 2026**
- Source: Finviz | 20260106T120741 | Somewhat-Bullish | Relevance: 100%
- AutoZone stock experienced a sharp drop in late 2025 due to narrowing profit margins but continues to grow, particularly through international expansion in the Americas. The company's aggressive store opening strategy and strong comparable sales growth in international markets are seen as key catalysts for future increased sales and earnings. While there are no current plans for European expansion, sustained growth in the Americas could eventually lead to new market exploration, presenting an attractive long-term buying opportunity.

**2. Vaughan Nelson Investment Management L.P. Sells 4,786 Shares of AutoZone, Inc. $AZO**
- Source: MarketBeat | 20260107T140921 | Somewhat-Bearish | Relevance: 100%
- Vaughan Nelson Investment Management L.P. has significantly reduced its stake in AutoZone, selling 4,786 shares, which represents a 42.3% decrease in its holdings and leaves the firm with 6,540 shares valued at approximately $28.06 million. This divestment follows AutoZone missing its quarterly EPS and revenue estimates, leading several analysts to trim price targets despite a consensus "Moderate Buy" rating. Insider activity showed net selling, with directors and the CFO engaging in both sales and purchases, and institutional investors collectively own 92.74% of the company's stock.

**3. AutoZone: It's In The Buy Zone (NYSE:AZO)**
- Source: Seeking Alpha | 20260107T131823 | Bullish | Relevance: 100%
- AutoZone is considered a compelling buy near its 52-week lows, as recent tariff-driven margin pressure seems to be priced into the stock. Despite a short-term EPS drop due to LIFO charges, the company's 8.2% revenue growth and ongoing store expansion highlight a resilient business model. A 12-month price target of $3,900 per share implies a 20% upside, anticipating normalized earnings growth and continued share buybacks.

**4. Sather Financial Group Inc Trims Stake in AutoZone, Inc. $AZO**
- Source: MarketBeat | 20260107T123853 | Somewhat-Bearish | Relevance: 100%
- Sather Financial Group Inc. reduced its stake in AutoZone, Inc. by 30.3% in Q3, selling 2,645 shares and ending with 6,097 shares valued at $26.16 million. This move comes despite analysts maintaining a "Moderate Buy" consensus for AutoZone, with an average price target of $4,330.84, even after a recent EPS miss and several downgrades. Notably, the company's CEO also significantly decreased his holding by selling 2,533 shares for $10.18 million, while institutional ownership remains high at 92.74%.

**5. AutoZone Stock Holds Its Lane: Solid Gains, Quiet Newsflow and a Cautious Wall Street Green Light**
- Source: AD HOC NEWS | 20260107T100827 | Somewhat-Bullish | Relevance: 100%
- AutoZone's stock has shown steady gains over the past year, despite muted trading volumes and a lack of significant news, trading like a "seasoned highway cruiser." Wall Street maintains cautious optimism, with most analysts issuing buy ratings and moderate price targets. The company's future prospects rely on its robust business model, share buyback program, and the continued high average age of vehicles in North America, though risks such as consumer spending slowdowns and increased competition persist.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 12)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Mizuho | $3550 | $3850 | -8% |
| 2025-12-18 | JP Morgan | $4100 | $4850 | -15% |
| 2025-12-16 | Wolfe Research | $0 | $0 | 0% |
| 2025-12-11 | Citigroup | $4200 | $4775 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Mizuho | down | Neutral |
| 2025-12-18 | JP Morgan | main | Overweight |
| 2025-12-16 | Wolfe Research | down | Peer Perform |
| 2025-12-11 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 20 ($1.93M) |
| Sells | 5 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.9% (+1.5%)
- Blackrock Inc.: 7.7% (-0.2%)
- JPMORGAN CHASE & CO: 6.4% (+68.9%)
- State Street Corpora: 4.3% (+0.1%)
- Geode Capital Manage: 2.7% (+1.0%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-1.6% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 12.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.78 elevated, pricing in significant growth expectations. Forward P/E 18.9x attractive for 19% earnings growth. Quality metrics strong (ROA 12%). Analyst sentiment negative (12 target cuts vs 0 raises). Insider buying signal ($1.9M), management confidence. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $55.2B |
| Beta | 0.42 |
| 52W Range | $3162.00 - $4388.11 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.78 |
| Forward P/E | 18.9 |
| Current P/E | 22.6 |
| YoY Growth | 19.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -0.5% to -2.0% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.0pp (needs >3.0% for momentum thesis). Below SMA200 (0.87x), long-term trend not supportive. MACD histogram bearish (-3.10), momentum weakening. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.00% (CS: 22) | Neutral |
| RSI_14 | 34.5 | Neutral |
| MACD Histogram | -3.10 | Bearish |
| vs SMA20 | 0.975x | Below |
| vs SMA50 | 0.912x | Below |
| vs SMA200 | 0.871x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $3320.19
- **Stop Loss:** $3170.45 (4.5% risk)
- **Target:** $3469.93 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 3
- **Position Value:** $9,960.57
- **Portfolio %:** 9.96%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $32.35 | $31.04 | -4.0% |
| 2025Q3 | $50.68 | $48.71 | -3.9% |
| 2025Q2 | $37.01 | $35.36 | -4.5% |
| 2025Q1 | $28.97 | $28.29 | -2.4% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_10*